TABLE 2.

Primary outcome: The proportion of women requiring a repeat infusion at each time point, n/N (%), and estimated difference in proportions between groups (90% CI)

Time period	500 mg (n = 152)	1000 mg (n = 126)	Estimated difference in proportions, 500–1000 mg (90% CI)
4 weeks post‐randomisation	26/73 (36%)	5/67 (8%)	0.283 (0.177–0.389)
6 weeks postpartum	39/118 (33%)	9/83 (11%)	0.234 (0.147–0.321)
3 months postpartum	15/98 (15%)	5/65 (8%)	0.086 (0.012–0.160)
6 months postpartum	15/88 (17%)	9/67 (13%)	0.037 (−0.059 to 0.133)
12 months postpartum	27/90 (30%)	14/70 (20%)	0.111 (−0.001 to 0.222)